Rituximab-induced serum sickness.
Schutgens
Roger E G
RE
Department of Haematology, University Medical Centre Utrecht, Utrecht, the Netherlands. r.schutgens@umcutrecht.nl
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D005260:Female; D006801:Humans; D007868:Leg Dermatoses / Q000139:chemically induced; D008875:Middle Aged; D000069283:Rituximab; D012713:Serum Sickness / Q000139:chemically induced*
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab